Abstract
Uterine sarcomas are rare malignant tumors of mesenchymal origin and account for 3–8 % of all uterine cancers [1, 2]. They are heterogeneous tumors of diverse histological types. The three most common subtypes are carcinosarcoma (CS) also known as malignant mixed Mullerian tumor (MMMT), leiomyosarcoma (LMS), and endometrial stromal sarcoma (ESS). Although recently carcinosarcoma has been reclassified as a dedifferentiated or metaplastic form of endometrial carcinoma [3], it is still included in most studies on uterine sarcomas. The important pure mesenchymal malignant tumors of the uterus are leiomyosarcoma (LMS) and endometrial stromal sarcoma (ESS). Uterine sarcomas are in general the most malignant group of uterine tumors and differ from endometrial cancers with respect to diagnosis, clinical behavior, pattern of spread, and management.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
